A Study of Toripalimab in Adjuvant Therapy After Resection of High-risk Renal Cancer
Clinical trial NCT06584435 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06584435
- Sponsor
- Tianjin Medical University Second Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-10
- Primary completion
- 2025-11-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.